101 related articles for article (PubMed ID: 29669096)
41. Out-of-field dose equivalents delivered by passively scattered therapeutic proton beams for clinically relevant field configurations.
Wroe A; Clasie B; Kooy H; Flanz J; Schulte R; Rosenfeld A
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):306-13. PubMed ID: 19100924
[TBL] [Abstract][Full Text] [Related]
42. Time-resolved diode dosimetry calibration through Monte Carlo modeling for in vivo passive scattered proton therapy range verification.
Toltz A; Hoesl M; Schuemann J; Seuntjens J; Lu HM; Paganetti H
J Appl Clin Med Phys; 2017 Nov; 18(6):200-205. PubMed ID: 29082601
[TBL] [Abstract][Full Text] [Related]
43. Performance of a high sensitivity multi-element tissue equivalent proportional counter for radiation protection neutron monitoring measurements.
Aslam ; Waker AJ
Health Phys; 2010 May; 98(5):692-703. PubMed ID: 20386199
[TBL] [Abstract][Full Text] [Related]
44. Water and tissue equivalence of a new PRESAGE(®) formulation for 3D proton beam dosimetry: a Monte Carlo study.
Gorjiara T; Kuncic Z; Doran S; Adamovics J; Baldock C
Med Phys; 2012 Nov; 39(11):7071-9. PubMed ID: 23127098
[TBL] [Abstract][Full Text] [Related]
45. FLUKA-BASED MONTE CARLO INVESTIGATION OF MICRODOSIMETRIC DISTRIBUTIONS OF TELECOBALT BEAM.
Selvam TP; Chattaraj A; Datta D
Radiat Prot Dosimetry; 2018 Mar; 178(4):430-440. PubMed ID: 29036422
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of neutron dose equivalent from the Mevion S250 proton accelerator: measurements and calculations.
Chen KL; Bloch CD; Hill PM; Klein EE
Phys Med Biol; 2013 Dec; 58(24):8709-23. PubMed ID: 24301001
[TBL] [Abstract][Full Text] [Related]
47. Measuring scatter radiation in diagnostic X rays for radiation protection purposes.
Vlachos I; Tsantilas X; Kalyvas N; Delis H; Kandarakis I; Panayiotakis G
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):382-5. PubMed ID: 25911405
[TBL] [Abstract][Full Text] [Related]
48. RADIATION PROTECTION MEASUREMENTS WITH THE VARIANCE-COVARIANCE METHOD IN THE STRAY RADIATION FIELDS FROM PHOTON AND PROTON THERAPY FACILITIES.
Lillhök J; Persson L; Andersen CE; Dasu A; Ardenfors O
Radiat Prot Dosimetry; 2018 Aug; 180(1-4):338-341. PubMed ID: 29036696
[TBL] [Abstract][Full Text] [Related]
49. An experimental demonstration of a new type of proton computed tomography using a novel silicon tracking detector.
Taylor JT; Poludniowski G; Price T; Waltham C; Allport PP; Casse GL; Esposito M; Evans PM; Green S; Manger S; Manolopoulos S; Nieto-Camero J; Parker DJ; Symons J; Allinson NM
Med Phys; 2016 Nov; 43(11):6129. PubMed ID: 27806609
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of radiation dose delivered by cone beam CT and tomosynthesis employed for setup of external breast irradiation.
Winey B; Zygmanski P; Lyatskaya Y
Med Phys; 2009 Jan; 36(1):164-73. PubMed ID: 19235385
[TBL] [Abstract][Full Text] [Related]
51. Microdosimetric evaluation of the 400 MeV/nucleon carbon beam at HIMAC.
Endo S; Tanaka K; Ishikawa M; Hoshi M; Onizuka Y; Takada M; Yamaguchi H; Hayabuchi N; Maeda N; Shizuma K
Med Phys; 2005 Dec; 32(12):3843-8. PubMed ID: 16475784
[TBL] [Abstract][Full Text] [Related]
52. A model-based analysis of a simplified beam-specific dose output in proton therapy with a single-ring wobbling system.
Kase Y; Yamashita H; Numano M; Sakama M; Mizota M; Maeda Y; Tameshige Y; Murayama S
Phys Med Biol; 2015 Jan; 60(1):359-74. PubMed ID: 25503686
[TBL] [Abstract][Full Text] [Related]
53. Out-of-field doses from secondary radiation produced in proton therapy and the associated risk of radiation-induced cancer from a brain tumor treatment.
Ardenfors O; Dasu A; Lillhök J; Persson L; Gudowska I
Phys Med; 2018 Sep; 53():129-136. PubMed ID: 30241747
[TBL] [Abstract][Full Text] [Related]
54. Validation of an in-vivo proton beam range check method in an anthropomorphic pelvic phantom using dose measurements.
Bentefour el H; Tang S; Cascio EW; Testa M; Samuel D; Prieels D; Gottschalk B; Lu HM
Med Phys; 2015 Apr; 42(4):1936-47. PubMed ID: 25832084
[TBL] [Abstract][Full Text] [Related]
55. Correlation of microdosimetric measurements with relative biological effectiveness from clinical experience for two neutron therapy beams.
Stinchcomb TG; Kuchnir FT; Myrianthopoulos LC; Horton JL; Roberts WK
Med Phys; 1986; 13(2):201-6. PubMed ID: 3702817
[TBL] [Abstract][Full Text] [Related]
56. STUDY FOR A PASSIVE SCATTERING LINE DEDICATED TO RADIOBIOLOGY EXPERIMENTS AT THE TRENTO PROTON THERAPY CENTER.
Tommasino F; Rovituso M; Lorentini S; La Tessa C; Petringa G; Cirrone P; Romano F; Scifoni E; Schwarz M; Durante M
Radiat Prot Dosimetry; 2019 May; 183(1-2):274-279. PubMed ID: 30535406
[TBL] [Abstract][Full Text] [Related]
57. Radiation Safety for Pregnant Workers at a Proton Facility.
Maquilan G; Bussière MR; McCormack J; Medich T; Niemierko A; Shih HA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):560-564. PubMed ID: 29306585
[TBL] [Abstract][Full Text] [Related]
58. Development and test of a GEM-based TEPC for neutron protection dosimetry.
Wang CK; Seidaliev M; Mandapaka A
Health Phys; 2008 May; 94(5):440-8. PubMed ID: 18403965
[TBL] [Abstract][Full Text] [Related]
59. THE RESPONSE OF A MULTI-ELEMENT TISSUE EQUIVALENT PROPORTIONAL COUNTER IN ACCELERATOR BASED HIGH-ALTITUDE NEUTRON FIELDS.
Orchard GM; Waker AJ
Radiat Prot Dosimetry; 2018 Aug; 180(1-4):142-145. PubMed ID: 29036384
[TBL] [Abstract][Full Text] [Related]
60. Dosimetric considerations on TEPC fluka-simulation and measurements.
Rollet S; Beck P; Ferrari A; Pelliccioni M; Autischer M
Radiat Prot Dosimetry; 2004; 110(1-4):833-7. PubMed ID: 15353755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
